Over £2 million raised for new urgent care centre following appeal Following an appeal from The Royal Marsden Cancer Charity to fund a new treatment and research facility, more than £2 million has been raised by partners from Goldman Sachs.
The Oak Cancer Centre Capital Appeal Board A highly committed Board of volunteers generously gave their time to help us raise more than £70 million for the Oak Cancer Centre.
Fundraising during the coronavirus pandemic During the Coronavirus pandemic, the safety of our supporters, volunteers and staff during this time remains our priority.
Why I left a gift in my Will Find out what inspires our supporters to leave a gift in their Will to The Royal Marsden Cancer Charity.
Volunteering for The Royal Marsden- Pearse's story Here we share the story of one of our amazing volunteers, Pearse, who has supported the Charity for the past 18 years.
Taking on an epic challenge for cancer research Simon Aylett has recently set off on an incredible 4,500-mile e-bike ride around the entire British coastline raising money for The Royal Marsden Cancer Charity.
Breakthrough treatments for oesophageal cancer patients Two new treatment options using immunotherapy for patients with advanced oesophageal cancer have shown significantly improved long-term survival, according to a study conducted at The Royal Marsden NHS Foundation Trust.
Philip Kingsley’s annual fundraising campaign We are delighted that British hair care brand Philip Kingsley will be supporting The Royal Marsden Cancer Charity this month, continuing their annual campaign which began in June 2017.
X-ray vision for young superheroes Thanks to funding from The Royal Marsden Cancer Charity, a new mobile X-ray machine can now provide fast, reliable and high-quality imaging from the ease of patients’ beds.
Your support helps The Royal Marsden lead on breakthrough treatments Exciting new treatments trialled at The Royal Marsden were presented at an annual international cancer conference held by the American Society of Clinical Onology (ASCO).
